Regulatory Show all
January 20 | 2025

2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE

Read more
January 10 | 2025

Correction: 2CUREX APPOINTS MANGOLD FONDKOMMISSION AB TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE

Read more
January 10 | 2025

2CUREX APPOINTS MANGOLD CORPORATE FINANCE TO ACT AS A LIQUIDITY PROVIDER FOR THE COMPANY’S SHARE

Read more
December 18 | 2024

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
December 18 | 2024

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
December 16 | 2024

2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of commercial expansion of breakthrough precision oncology products

Read more
November 29 | 2024

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB

Read more
November 29 | 2024

NOTICE OF EXTRA GENERAL MEETING IN 2CUREX AB

Read more
September 24 | 2024

BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)

Read more
September 24 | 2024

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
September 9 | 2024

Invitation to 2cureX Webcast with Q&A on 24 September 2024

Read more
September 4 | 2024

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBKL)

Read more
August 22 | 2024

2cureX publishes interim report for the first half year of 2024

Read more
July 12 | 2024

KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
July 1 | 2024

KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)

Read more
June 28 | 2024

RELEASE OF THE 2CUREX AB (PUBL) ANNUAL REPORT

Read more
June 28 | 2024

PUBLICERING AV ÅRSREDOVISNINGEN FÖR 2CUREX AB (PUBL)

Read more
June 26 | 2024

EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

Read more